Muscarinic cholinergic and β-adrenergic contribution to hindquarters vasodilation and cardiac responses to cocaine

Journal of Pharmacology and Experimental Therapeutics

Volumn 306, Issue 2, 2003, Pages 515-522

  Knuepfer, Mark M ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; ATENOLOL; ATROPINE METHYL BROMIDE; BETA 2 ADRENERGIC RECEPTOR; COCAINE; METHOCTRAMINE; MUSCARINIC M1 RECEPTOR AGONIST; MUSCARINIC M2 RECEPTOR; MUSCARINIC M2 RECEPTOR AGONIST; PIRENZEPINE; PROPRANOLOL;

ADRENERGIC ACTIVITY; ANIMAL EXPERIMENT; AORTA FLOW; ARTERIAL PRESSURE; ARTICLE; ASCENDING AORTA; BLOOD VESSEL REACTIVITY; CHOLINERGIC ACTIVITY; COLOR ULTRASOUND FLOWMETRY; CONTROLLED STUDY; DESCENDING AORTA; DRUG EFFECT; HEART; HEART OUTPUT; HEART STROKE VOLUME; HINDLIMB; MALE; NONHUMAN; PRESSOR RESPONSE; PRIORITY JOURNAL; RAT; SKELETAL MUSCLE; SYSTEMIC VASCULAR RESISTANCE; VASOCONSTRICTION; VASODILATATION;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; BLOOD PRESSURE; CARDIAC OUTPUT; COCAINE; HEART; HEART RATE; HEMODYNAMIC PROCESSES; MALE; MUSCARINIC ANTAGONISTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, MUSCARINIC M2; RECEPTORS, ADRENERGIC, BETA; RECEPTORS, MUSCARINIC; STROKE VOLUME; VASOCONSTRICTOR AGENTS; VASODILATION;

EID: 0037622747     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.103.051177     Document Type: Article

References (40)

1. Abrahams TP, Cuntapay M, and Varner KJ (1996) Sympathetic nerve responses elicited by cocaine in anesthetized and conscious rats. Physiol Behav 59:109-115.
2. Branch CA and Knuepfer MM (1992) Adrenergic mechanisms underlying cardiac and vascular responses to cocaine in conscious rats. J Pharmacol Exp Ther 263: 742-751.
3. Branch CA and Knuepfer MM (1994a) Causes of differential cardiovascular sensitivity to cocaine I: studies in conscious rats. J Pharmacol Exp Ther 269:674-683.
4. Branch CA and Knuepfer MM (1994b) Causes of differential cardiovascular sensitivity to cocaine II: sympathetic metabolic and cardiac effects. J Pharmacol Exp Ther 271:1103-1113.
5. Chiueh CC and Kopin IJ (1978) Centrally mediated release by cocaine of endogenous epinephrine and norepinephrine from the sympathoadrenal medullary system of unanesthetized rats. J Pharmacol Exp Ther 205:148-154.
6. Dong HW, Gan Q, and Knuepfer MM (2001) Central corticotropin releasing factor and adrenergic receptors mediate hemodynamic responses to cocaine. Brain Res 893:1-10.
7. Eglen RM and Watson N (1996) Selective muscarinic receptor agonists and antagonists. Pharmacol Toxicol 78:59-68.
8. Flynn DD, Vaishnav AA, and Mash DC (1992) Interactions of cocaine with primary and secondary sites on muscarinic receptors. Mol Pharmacol 41:736-742.
9. Foltin RW, Fischman MW, and Levin FR (1995) Cardiovascular effects of cocaine in humans: laboratory studies. Drug Alcohol Depend 37:193-210.
10. Hammer R and Giachetti A (1982) Muscarinic receptor subtypes: M1 and M2 biochemical and functional characterization. Life Sci 31:2991-2998.
11. Herd JA (1991) Cardiovascular response to stress. Physiol Rev 71:305-330.
12. Jacobsen TN, Grayburn PA, Snyder RW, Hansen J, Chavoshan B, Landau C, Lange RA, Hillis LD, and Victor RG (1997) Effects of intranasal cocaine on sympathetic nerve discharge in humans. J Clin Investig 99:628-634.
13. Javaid J, Fischman MW, Schuster CR, Dekirmenjian H, and Davis JM (1978) Cocaine plasma concentrations: relation to physiological and subjective effects in humans. Science (Wash DC) 202:227-228.
14. Kenny D, Pagel PS, and Warltier DC (1992) Attenuation of the systemic and coronary hemodynamic effects of cocaine in conscious dogs: propranolol versus labetalol. Basic Res Cardiol 87:465-477.
15. 2-adrenoceptors in cardiovascular response of rats to acute stressors. Am J Physiol 258:H683-H688.
16. Kiritsy-Roy JA, Halter JB, Gordon SM, Smith MJ, and Terry LC (1990) Role of the central nervous system in hemodynamic and sympathoadrenal responses to cocaine in rats. J Pharmacol Exp Ther 255:154-160.
17. Knuepfer MM (2003) Cardiovascular disorders associated with cocaine use: myths and truths. Pharmacol Ther 97:181-222.
18. Knuepfer MM and Branch CA (1992) Cardiovascular responses to cocaine are initially mediated by the central nervous system in rats. J Pharmacol Exp Ther 263:734-741.
19. Knuepfer MM, Branch CA, Wehner DM, Gan Q, and Hoang D (1994) Non-adrenergic mechanisms of cocaine-induced regional vascular responses in rats. Can J Physiol Pharmacol 72:335-343.
20. Knuepfer MM and Gan Q (1999) Role of cholinergic receptors and cholinesterase activity in hemodynamic responses to cocaine in conscious rats. Am J Physiol 276:R103-R112.
21. Knuepfer MM, Gan Q, and Mueller PJ (1998) Mechanisms of hemodynamic responses to cocaine in conscious rats. J Cardiovasc Pharmacol 31:391-399.
22. Knuepfer MM, Han S-P, Trapani AJ, Fok KF, and Westfall TC (1989) Regional hemodynamic and baroreflex effects of endothelin in rats. Am J Physiol 257: H918-H926.
23. Knuepfer MM and Mueller PJ (1999) Review of evidence for a novel model of cocaine-induced cardiovascular toxicity. Pharmacol Biochem Behav 63:489-500.
24. Knuepfer MM, Purcell RM, Gan Q, and Le KM (2001) Hemodynamic response patterns to acute behavioral stressors resemble those to cocaine. Am J Physiol 281:R1778-R1786.
25. Lavallée M, de Champlain J, Nadeau RA, and Yamaguchi N (1978) (1978) Muscarinic inhibition of endogenous myocardial catecholamine liberation in the dog. Can J Physiol Pharmacol 56:642-649.
26. Liu J and Lee TJ (1999) Mechanism of prejunctional muscarinic receptor-mediated inhibition of neurogenic vasodilation in the cerebral arteries. Am J Physiol 276: H194-H204.
27. MacIagan J, Fryer AD, and Faulkner D (1989) Identification of M1 muscarinic receptors in pulmonary sympathetic nerves in the guinea-pig by use of pirenzipine. Br J Pharmacol 97:499-505.
28. McAinsh J and Cruickshank JM (1990) β-Blockers and central nervous system side effects. Pharmacol Ther 46:163-197.
29. Miao L, Qui Z, and Morgan JP (1996) Cholinergic stimulation modulates negative inotropic effect of cocaine on ferret ventricular myocardium. Am J Physiol 270: H678-H684.
30. Muscholl E (1980) Peripheral muscarinic control of norepinephrine release in the cardiovascular system. Am J Physiol 239:H713-H720.
31. 3H]cocaine in acutely and chronically treated rats. J Pharmacol Exp Ther 196:556-569.
32. Purcell RM, Gan Q, and Knuepfer MM (2001). Variable renal sympathetic responses to cocaine in rats (Abstract). FASEB J 15:A801.
33. Shannon RP, Stambler BS, Komamura K, Ihara T, and Vatner SF (1993) Cholinergic modulation of the coronary vasoconstriction induced by cocaine in conscious dogs. Circulation 87:939-949.
34. Sharkey J, Ritz MC, Schenden JA, Hanson RC, and Kuhar MJ (1988) Cocaine inhibits muscarinic cholinergic receptors in heart and brain. J Pharmacol Exp Ther 246:1048-1052.
35. Tella SR, Schindler CW, and Goldberg SR (1993) Cardiovascular effects in relation to peripheral neuronal monoamine uptake and central stimulation of the sympathoadrenal system. J Pharmacol Exp Ther 267:153-162.
36. van Zwieten PA and Timmermans PBMWM (1979) Comparison between the acute hemodynamic effects and brain penetration of atenolol and metoprolol. J Cardiovasc Pharmacol 1:85-96.
37. Vongpatanasin W, Mansour Y, Chavoshan B, Arbique D, and Victor RG (1999) Cocaine stimulates the human cardiovascular system via a central mechanism of action. Circulation 100:497-502.
38. 2-cholinoceptors. Naunyn-Schmiedeberg's Arch Pharmacol 338:19-27.
39. Wilkerson RD (1988) Cardiovascular effects of cocaine in conscious dogs: importance of fully functional autonomic and central nervous systems. J Pharmacol Exp Ther 246:466-471.
40. 2 muscarinic receptor-mediated inhibition of endogenous noradrenaline release from the vascularly perfused rat stomach. J Pharmacol Exp Ther 264:54-60.